TPST

Tempest Therapeutics, Inc.

Healthcare · Biotechnology

$251.78 sample

+1.08 (+0.43%) 1D

Market cap

$1.62T

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$251.78 -3.46% 3M daily closessample

260.81241.34

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider buy: Chief Executive Officer
Oct 06INSInsider sell: Director
Sep 29INSInsider sell: Chief Executive Officer
Sep 18INSInsider sell: 10% owner
Sep 09INSInsider sell: Chief Financial Officer
Sep 01INSInsider sell: Director
Aug 26INSInsider sell: EVP, Operations
Aug 18INSInsider sell: Director

Sign up to see the real TPST record →

Company facts

SEC EDGAR registration

Name: Tempest Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +17sample, -100 to +100
Reporting currency: USD

Who is positioning in TPST

sample

Insiders: 23 insider transactions over 90 days, net selling, $407.6M
Congress: No member trades over 90 days
Institutions · 13F: 10 funds hold $29.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$71.9B +16.0% y/y

Q4 2024Q3 2026

Inventory$40.9B +9.3% y/y

Q4 2024Q3 2026

Accounts receivable$32.5B +22.0% y/y

Q4 2024Q3 2026

Total debt$84.6B +15.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $593.6B +6.0% 3M
Sample peer B: $948.9B +13.4% 3M
Sample peer C: $1.42T -10.9% 3M
Sample peer D: $649.7B +1.3% 3M
Sample peer E: $814.2B +5.5% 3M